Baxter International Inc vs Invesco Solar ETF — how do they compare? Baxter International Inc trades at $21.78 (market cap $11.26B), while Invesco Solar ETF trades at $55.58. The key difference: Baxter International Inc pays a 0.92% dividend while Invesco Solar ETF pays none. Which is the better fit depends on your goals.
| BAX | TAN | |
|---|---|---|
Market Cap | $11.26B | — |
Sector | Health | Sector/Thematic |
52-Week High | $29.22 | $73.95 |
52-Week Low | $15.80 | $36.07 |
Enterprise Value | $18.93B | — |
Dividend Yield | 0.92% | — |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.
BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.
Invesco Solar ETF (TAN) trades at $53.12, down 3.35% amid a bearish technical signal with 18 sell indicators. The fund focuses on utility-scale solar and grid technology, benefiting from AI-driven electricity demand but facing headwinds from policy uncertainty and supply chain costs. Recent news highlights both long-term growth potential and near-term volatility.
Outlook is mixed: strong structural demand for clean energy supports long-term growth, but regulatory risks and technical weakness pose challenges. Investors should weigh exposure to solar's AI-driven expansion against policy sensitivity and current bearish momentum.
Trailing returns across standard periods
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →